Inter-Regional Epidemiological Study of Childhood Cancer (IRESCC): childhood cancer and the consumption of debendox and related drugs in pregnancy.

Author: BirchJ M, CartwrightR A, HartleyA L, HoptonP A, JohnstonH E, MannJ R, McKinneyP A, StillerC A, WaterhouseJ A

Paper Details 
Original Abstract of the Article :
Attention has recently focused on the possible teratogenic effects of the combination antiemetic doxylamine succinate, dicyclomine hydrochloride and pyridoxine hydrochloride (Debendox/Bendectin) prescribed to pregnant women. The Inter-Regional Epidemiological Study of Childhood Cancer (IRESCC), a ca...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1038/bjc.1985.278

データ提供:米国国立医学図書館(NLM)

Debendox and Childhood Cancer: Investigating a Potential Link

This research investigates the potential teratogenic effects of Debendox, a combination antiemetic drug, on the risk of childhood cancer. The study, conducted by the Inter-Regional Epidemiological Study of Childhood Cancer (IRESCC), involved a large cohort of mothers of children with cancer and control children. The researchers analyzed data collected through interviews and medical records, comparing the incidence of childhood cancer in children exposed to Debendox during pregnancy to those not exposed. The study found no evidence to suggest that Debendox increases the risk of developing childhood cancer.

No Link Found Between Debendox and Childhood Cancer

This research provides reassurance that Debendox, an antiemetic medication commonly used during pregnancy, does not appear to increase the risk of childhood cancer. This finding is significant, as it helps to address concerns about the potential teratogenic effects of this medication. It's like finding a safe oasis in a vast desert, providing comfort and assurance to expectant mothers.

What Does This Mean for You?

This study offers reassurance to expectant mothers, suggesting that Debendox, when used as directed, does not appear to increase the risk of childhood cancer. It's important to remember that every pregnancy is unique, and consulting with your doctor is always recommended. Just as a camel navigates a desert seeking water, it's vital to seek guidance from trusted sources in your health journey.

Dr.Camel's Conclusion

This study provides valuable information for expectant mothers, dispelling concerns about the potential teratogenic effects of Debendox. It's a reminder that scientific research is essential for guiding our understanding of health and well-being, helping us navigate the complexities of our lives with confidence. Just as a camel relies on its instincts to navigate the desert, we can rely on scientific evidence to make informed choices about our health.

Date :
  1. Date Completed 1986-02-11
  2. Date Revised 2019-05-15
Further Info :

Pubmed ID

4074645

DOI: Digital Object Identifier

10.1038/bjc.1985.278

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.